ZA201907938B - Stable monolithic fast-release pharmaceutical form of ezetimibe and rosuvastatin - Google Patents
Stable monolithic fast-release pharmaceutical form of ezetimibe and rosuvastatinInfo
- Publication number
- ZA201907938B ZA201907938B ZA2019/07938A ZA201907938A ZA201907938B ZA 201907938 B ZA201907938 B ZA 201907938B ZA 2019/07938 A ZA2019/07938 A ZA 2019/07938A ZA 201907938 A ZA201907938 A ZA 201907938A ZA 201907938 B ZA201907938 B ZA 201907938B
- Authority
- ZA
- South Africa
- Prior art keywords
- ezetimibe
- rosuvastatin
- release pharmaceutical
- pharmaceutical form
- stable monolithic
- Prior art date
Links
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title 1
- 229960000815 ezetimibe Drugs 0.000 title 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
- 229960000672 rosuvastatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20180100533A GR1009727B (el) | 2018-11-28 | 2018-11-28 | Μονολιθικη σταθερη φαρμακοτεχνικη μορφη ταχειας αποδεσμευσης εζετιμιμπης και ροσουβαστατινης |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201907938B true ZA201907938B (en) | 2021-09-29 |
Family
ID=71107293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/07938A ZA201907938B (en) | 2018-11-28 | 2019-11-27 | Stable monolithic fast-release pharmaceutical form of ezetimibe and rosuvastatin |
Country Status (2)
| Country | Link |
|---|---|
| GR (1) | GR1009727B (el) |
| ZA (1) | ZA201907938B (el) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009024889A2 (en) * | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| WO2011019326A2 (en) * | 2009-07-02 | 2011-02-17 | Mahmut Bilgic | Solubility and stability enchancing pharmaceutical formulation |
| WO2011139256A2 (en) * | 2010-05-04 | 2011-11-10 | Bilgic Mahmut | Stable rosuvastatin formulations |
| KR20150079373A (ko) * | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| EP3243506A1 (en) * | 2016-05-09 | 2017-11-15 | Adamed sp. z o.o. | Pharmaceutical composition |
-
2018
- 2018-11-28 GR GR20180100533A patent/GR1009727B/el active IP Right Grant
-
2019
- 2019-11-27 ZA ZA2019/07938A patent/ZA201907938B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR1009727B (el) | 2020-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279464A (en) | Pharmaceutical formulation of odevixibat | |
| IL287445A (en) | A quinazoline compound and its pharmacologic use | |
| IL292439A (en) | Pharmaceutical preparations of albumin and rapamycin | |
| IL290745A (en) | A pyrimidine compound and its pharmaceutical use | |
| IL275220A (en) | Oral administration of active drug substances | |
| ZA202004982B (en) | Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin | |
| IL277694A (en) | Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidine | |
| EP4335517B8 (en) | Administration and dosage of diaminophenothiazines | |
| GB2581117B (en) | Dynamic delivery of software functions | |
| IL280596A (en) | Anti-IL-1 antibody in a cell, its pharmaceutical preparation and its use | |
| IL276311A (en) | Methyllactam ring compound and its pharmaceutical use | |
| IL276326A (en) | Dihydropyrimidinone or dihydrotriazinone compounds with a saturated compressed ring and their pharmaceutical use | |
| IL279622A (en) | Pharmaceutical formulations of masked antibodies | |
| IL278517A (en) | Azabenzaimidazole compounds and pharmaceutical preparations | |
| IL276323A (en) | 4-Methyldihydropyrimidinone compounds and their pharmaceutical use | |
| ZA201907938B (en) | Stable monolithic fast-release pharmaceutical form of ezetimibe and rosuvastatin | |
| SI3829547T1 (sl) | Farmacevtska sestava tikagrelorja | |
| HK40078214A (en) | Pharmaceutical compounds and methods of use | |
| IL313750A (en) | A system for administering drugs and methods for using it | |
| HK40055896A (en) | Pharmaceutical formulations of masked antibodies | |
| ZA202205263B (en) | Solid pharmaceutical forms of perampanel | |
| EP3889157C0 (en) | SALT AND CRYSTALLINE FORM OF A FUROPYRIMIDINE COMPOUND AND THEIR PHARMACEUTICAL USE | |
| HK40052480A (zh) | 奥德昔巴特的药物制剂 | |
| HK40031593A (en) | Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same | |
| GB201710382D0 (en) | Administration and dosage of Diaminophenothiazines |